Get to know the
candidates on the short list.
了解短名单上的候选人。
Mark is the best candidate for the post of chairman。
马克是董事长职位的最佳候选人。
He was the only candidate; therefore, he was elected.
他是唯一的候选人,因此他当选了。
The company has finalized the list of candidates; the new employees are expected to complete six weeks of training in London and start work early this summer.
该公司已经敲定了候选人名单；新员工预计将在伦敦完成为期六周的培训，并于今年夏初开始工作。
China is growing, and we definitely want to be part of that," said Calum Laming, British Airways' chief customer officer, who visited Beijing recently to interview candidates for the final round.
英国航空公司首席客户官Calum Laming最近访问了北京，面试了最后一轮的候选人。
"While actively preparing for the commercial launch of Nefecon and bringing this first-in-disease therapy to patients in China as soon as possible, the company will continue to develop other innovative drug candidates in renal and auto-immune diseases to benefit more Chinese and Asian patients," he said.
他说：“在积极准备Nefecon的商业上市并尽快将这一首个疾病治疗推向中国患者的同时，该公司将继续开发其他肾脏和自身免疫疾病的创新候选药物，使更多中国和亚洲患者受益。”。
"In addition to attracting experienced candidates, the need to recruit young talent is increasingly urgent for a more sustainable development of Airbus in China.
“除了吸引有经验的候选人外，招聘年轻人才的需求也越来越迫切，这是空客在中国更可持续发展的需要。
During the CIIE, Boehringer Ingelheim also exhibited a new drug candidate at the Phase-3 clinical trial for treating idiopathic pulmonary fibrosis, a rare and chronic lung disease.
在CIIE期间，勃林格殷格翰还在治疗特发性肺纤维化（一种罕见的慢性肺病）的3期临床试验中展示了一种新的候选药物。
Candidates thus have to improve their own value to find the right jobs.
因此，求职者必须提高自己的价值才能找到合适的工作。
The company has hired 100 mainland flight attendants this year for the first time, in an aim to diversify its cabin crew members with the ability to speak mandarin, with more than 2,000 candidates filing applications.
该公司今年首次雇佣了100名大陆空乘人员，旨在使其客舱乘务员多样化，使其能够说普通话，有2000多名候选人提出申请。
GSK has 23 other vaccine candidates in the development stage, including a respiratory syncytial virus (RSV) vaccine, which was approved by the United States Food and Drug Administration in May for the prevention of RSV infection in people aged 60 or older.
葛兰素史克还有23种其他候选疫苗处于开发阶段，其中包括一种呼吸道合胞病毒（RSV）疫苗，该疫苗于5月被美国食品和药物管理局批准用于预防60岁或以上人群感染RSV。
Last year, among candidates applying for jobs at GE HealthCare China, more than 70 percent were female candidates, according to the company's statistics.
根据通用电气中国公司的统计数据，去年，在通用电气中国医疗保健的求职者中，超过70%是女性。
So far, more than 2,000 candidates have filed applications.
到目前为止，已有2000多名候选人提出申请。
"The company will continue to advance the approval and commercialization of other drug candidates to further address urgent unmet needs in China and the rest of Asia," he said.
他说：“该公司将继续推进其他候选药物的审批和商业化，以进一步解决中国和亚洲其他地区尚未满足的紧迫需求。”。
"Try to picture a situation where AI can help your hiring managers write compelling job descriptions, and quickly generate interview questions tailored to different candidates.
“试着想象一种情况，人工智能可以帮助招聘经理撰写引人注目的职位描述，并快速生成针对不同候选人的面试问题。
The company has announced its formulation of a candidate COVID-19 vaccine, with clinical trials scheduled to kick off in China this year.
该公司宣布了其候选新冠肺炎疫苗的配方，临床试验计划于今年在中国启动。
"To build our park in Daya Bay is a decision we made after a comprehensive review of a number of investment candidates around the world," Zhou said.
周说：“在大亚湾建设我们的园区是我们对世界各地的一些投资候选人进行全面审查后做出的决定。”。
Progress has also been made with the development candidate aflibercept 8 mg, which was compared with Eylea™ containing 2xa0mg of aflibercept in two pivotal studies.
与Eylea相比，开发候选药物8 mg的阿法西普也取得了进展™ 在两项关键研究中含有2xa0mg的阿法西普。
The financial threshold for setting up a finance company has been raised in line with China's economic status, with higher asset, revenue, profit and paid-in capital requirements for candidate corporate groups, according to the draft document.
根据文件草案，设立财务公司的财务门槛已根据中国的经济状况提高，候选企业集团的资产、收入、利润和实收资本要求更高。
Applications for the program will be taken from July 1 to Sept 30, and the candidates will be screened by a committee of well-known scientists.
该项目的申请将于7月1日至9月30日进行，候选人将由知名科学家委员会进行筛选。
Candidates working in the program's experimental category can receive up to 5 million yuan per year, while those in theoretical fields of study can receive a maximum of 3 million yuan annually.
该项目实验类的考生每年最高可获得500万元，而理论研究领域的考生每年最多可获得300万元。
"Our most important criteria for selecting candidates are to see whether their past research had global impacts, and whether their future research would be at the forefront of basic sciences," he said.
他说：“我们选择候选人最重要的标准是看他们过去的研究是否具有全球影响，以及他们未来的研究是否会处于基础科学的前沿。”。
"We want the candidates to be ambitious and go in a research direction that no one else has tried.
“我们希望候选人雄心勃勃，朝着其他人都没有尝试过的研究方向前进。
Through this proposed partnership with CR Pharma, the mRNA-focused company will be well-positioned to advance its potentially best-in-class mRNA vaccine candidates through Chinese regulatory pathways and into commercialization, Everest said.
Everest表示，通过与CR Pharma的拟议合作，这家专注于信使核糖核酸的公司将处于有利地位，能够通过中国的监管途径推进其潜在的同类最佳信使核糖核酸候选疫苗并实现商业化。
The mRNA company will accelerate the late-stage development and registration of its potentially best-in-class mRNA COVID-19 vaccine candidate, PTX-COVID19-B, and continue the development of a second-generation COVID-19 vaccine with broad spectrum activity designed to be effective against but not limited to the Omicron variants, as well as two Collaboration Project with Providence that target new mRNA based vaccines, Everest said.
mRNA公司将加快其潜在的最佳mRNA新冠肺炎候选疫苗PTX-COVID19-B的后期开发和注册，并继续开发具有广谱活性的第二代新冠肺炎疫苗，该疫苗旨在有效对抗但不限于奥密克戎变异株，以及与普罗维登斯的两个针对新型信使核糖核酸疫苗的合作项目，Everest说。
This year, Yang was selected as a candidate for the foundation's project to empower intangible cultural heritage entrepreneurship and address the challenges faced by ethnic minority rural women, enabling them to live a good life without leaving their hometown.
今年，杨被选为该基金会项目的候选人，该项目旨在为非物质文化遗产创业赋能，并应对少数民族农村妇女面临的挑战，使她们能够不离开家乡就过上好日子。
HUTCHMED, a Chinese biopharmaceutical company, has advanced 12 cancer drug candidates it manufactured to clinical research stage around the world.
中国生物制药公司HUTCHMED已将其生产的12种癌症候选药物推向全球临床研究阶段。
The agreement said Adagene, founded in Suzhou, Jiangsu province in 2012, will be responsible for early-stage research activities to develop versions of Sanofi candidate antibodies, using Adagene's proprietary technology.
协议称，2012年在江苏省苏州市成立的阿达吉恩将负责利用阿达吉恩的专有技术开发赛诺菲候选抗体的早期研究活动。
By engineering and developing therapeutic antibody candidates to selectively activate in the tumor microenvironment, the platform is designed to improve safety and tolerability of antibody therapeutics while maintaining clinical activity.
通过设计和开发治疗性候选抗体以在肿瘤微环境中选择性激活，该平台旨在提高抗体治疗的安全性和耐受性，同时保持临床活性。
Clover Biopharmaceuticals Ltd, a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, announced on Wednesday the construction of a new research and development center in Zhangjiang Biotech and Pharmaceutical Industrial Base in Shanghai.
三叶草生物制药有限公司，一家开发新型疫苗和候选生物治疗药物的全球临床生物技术公司，周三宣布在上海张江生物技术和制药工业基地建设一个新的研发中心。
Clover intends to recruit hundreds of new hires from the area's deep talent pool to supplement its existing R&D capabilities and accelerate the development of multiple new product candidates.
三叶草计划从该地区的深层人才库中招聘数百名新员工，以补充其现有的研发能力，并加快开发多种新产品。
Clover Biopharmaceuticals, a Chinese clinical-stage biopharma company developing vaccines and oncology drugs, announced on Wednesday that its protein-based COVID-19 vaccine candidate was found to be 67 percent effective against COVID-19 of any degree of severity and 79 percent against the highly infectious Delta variant in a large late-stage trial.
The vaccine, deploying proteins on the coronavirus to stimulate immunity against COVID-19, is also the first COVID-19 vaccine candidate in the world to demonstrate in a randomized trial significantly reduced risk of COVID-19 disease in previously infected individuals, a growing and increasingly important population as the virus continues to spread worldwide, the company claimed.
"Based on our pioneering data, we believe that SCB-2019 (the vaccine candidate) could be utilized as an important tool to combat this pandemic, and we remain dedicated to expediting the availability and equitable access of our COVID-19 vaccine candidate for global distribution," Liang said.
According to an advance purchase agreement with Gavi, or the Vaccine Alliance, the company will provide up to 414 million doses of its protein-based COVID-19 vaccine candidate for procurement through the COVAX facility.
The company said the new drug candidate to treat drug-resistant CML patients has been granted orphan drug and fast track designations by the United States Food and Drug Administration.
It is also doubling down on a talent training system dubbed Fast Trak, looking to increase the venue, personnel and financial input to construct Asia's largest biopharma candidate hub and intelligent manufacturing showroom.
Under the partnership, Everest is licensed rights to Providence's mRNA COVID-19 vaccine candidates in Asian emerging markets, including China, Southeast Asia and Pakistan.
Providence's lead mRNA COVID-19 vaccine candidate, which is currently in Phase 2 clinical trials, has demonstrated it is generally safe and well-tolerated and that the dosed subjects have high neutralization titers against the original strain of SARS-CoV-2 in an S protein-typed pseudovirus assay.
It is conducting more than 40 Phase I and II clinical trials for its eight original innovative drug candidates in the US, Australia, Europe and China.
A key drug candidate was developed for the treatment of drug-resistant chronic myeloid leukemia, which affects an estimated 10,000 patients in the country each year, said Yang Dajun, chairman and CEO of Ascentage Pharma.
Beijing-based YishengBio Co Ltd announced during the fair that its PIKA recombinant COVID-19 vaccine, an innovative prophylactic and therapeutic vaccine candidate against multiple SARS-CoV-2 variants, has won clinical trial approval from health authorities in the United Arab Emirates to treat patients with mild to moderate SARS-CoV-2 infections.
According to Chen, the company's recombinant vaccine candidate has finished first and second-phase clinical trials in China with favorable results.
That includes the updated versions of its two approved inactivated vaccines, two vaccine candidates under development via recombinant and mRNA technologies, and three test kits.
The company established in 2009 has more than 40 Phase I and II clinical trials underway for its eight originally innovative drug candidates in the US, Australia, Europe and China.
One of the major exhibits at the fair will be its core drug candidate developed for the treatment of drug-resistant chronic myeloid leukemia (CML), which afflicts an estimated 10,000 patients in the country each year, Yang said.
Altogether, four of the company's candidate drugs have been granted 12 orphan drug qualifications by the US FDA so far, allowing it to become the enterprise with the largest number of such qualifications domestically, according to the company.
At the fair in Beijing, the company will ink strategic collaborations with different players in the health sector, including a precise testing provider, and insurance companies, to prepare to help patients use the right therapy, improve drug accessibility, and ease patients' financial burden after the drug candidate's market approval, which may be expected in the fourth quarter of this year.
US-based Biogen Inc and Hong Kong-listed Chinese mainland biopharma startup InnoCare Pharma Ltd announced on Monday that they have entered into a license and collaboration agreement for orelabrutinib, a drug candidate currently in a multi-country, placebo-controlled Phase 2 trial for the potential treatment of multiple sclerosis, a rare disease of the nervous system characterized by loss of feeling and control of movement and speech.
Wang Yinxiang, chairman and CEO of Jacobio, said the company is the second drug developer in the world to engage in clinical development of an SHP2 inhibitor drug candidate, following Novartis.
The study is a global pivotal Phase 2/3 clinical trial evaluating the efficacy, safety and immunogenicity of SCB-2019 (CpG 1018/Alum), Clover's COVID-19 vaccine candidate.
Chinese clinical-stage biotech Clover Biopharmaceuticals and Nasdaq-listed Dynavax Technologies Corp, a biopharmaceutical company focused on developing and commercializing novel vaccines, announced on Wednesday a commercial supply agreement of Dynavax's CpG 1018TM advanced adjuvant for use in Clover's protein-based COVID-19 vaccine candidate, SCB-2019 (CpG 1018/Alum).
Clover Biopharmaceuticals, a clinical-stage Chinese biotech developing novel vaccines and biologic therapeutic candidates to address the world's most life-threatening diseases and public health threats, announced on Wednesday an advance purchase agreement with Gavi, or the Vaccine Alliance.
According to the agreement, the company is to provide up to 414 million doses of its protein-based COVID-19 vaccine candidate for procurement through the COVAX facility.
Pending an Emergency Use Listing from the World Health Organization for Clover's COVID-19 vaccine candidate, Clover will make an initial 64 million doses available for procurement through the COVAX facility in 2021.
The agreement also contains the opportunity to access Clover variant-adapted COVID-19 vaccine candidates.
"The pandemic continues to have a profound impact on the world, and we remain dedicated to expediting the availability of our COVID-19 vaccine candidate for procurement and global distribution," Liang said.
Insilico Medicine demonstrated the first case of AI identifying a novel target for a major pulmonary disease, generating novel molecules for that novel target, and completing the preclinical experiments required to nominate a preclinical candidate in under 18 months.
This forces the CEO to either look for another candidate, or dedicate their energies toward convincing their unwilling first-choice successor.
This can manifest in many different ways, from potential successors being more willing to learn from CEOs' experience, to enlarging the pool of viable successor candidates, reducing familial infighting over the succession, and generally creating a more harmonious environment for knowledge transfer and the strategic consideration of who is the most suitable candidate for the job.
Chinese clinical-stage biotech Clover Biopharmaceuticals and Nasdaq-listed biopharmaceutical company Dynavax Technologies Corporation announced on Wednesday the first participants have been dosed in Clover's global Phase 2/3 clinical trial evaluating the efficacy, safety and immunogenicity of its protein-based S-Trimer COVID-19 vaccine candidate adjuvanted with Dynavax's CpG 1018 plus alum.
The global Phase 2/3 trial is a double-blind, randomized, controlled study of the adjuvanted S-Trimer COVID-19 vaccine candidate in a two-dose regimen, given 21 days apart.
Joshua Liang, CEO of Clover Biopharmaceuticals, said there is still a significant need in many global communities for COVID-19 vaccines and should the Phase 2/3 interim analysis be favorable, the company will work closely with regulatory authorities worldwide to make the S-Trimer COVID-19 vaccine candidate available as soon as possible.
Ryan Spencer, CEO of Dynavax, said Clover's adjuvanted vaccine candidate has the potential to be an important additional solution to address worldwide demand, since it can be manufactured at large scale and stored at standard refrigeration temperature.
In December 2020, Clover reported positive clinical data from its Phase 1 trial, demonstrating its protein-based COVID-19 S-Trimer vaccine candidate in combination with Dynavax's CpG 1018 induces strong immune response, including neutralizing antibodies and cell-mediated immunity, as well as favorable safety and tolerability profiles in the adult and elderly participants.
The vaccine candidate is expected to be stable long-term under standard refrigeration conditions and has demonstrated stability at room temperature for at least two months, making it suitable for global distribution.
Clover expects to initiate a global Phase 2/3 efficacy trial for SCB-2019 (S-Trimer), its COVID-19 vaccine candidate, in the first half of 2021 and has initiated production planning for potentially hundreds of millions of vaccine doses in 2021.
Michael Yi, co-CIO and partner of Hillhouse Capital, said Clover has had a tremendous year of growth with the rapid advancement of the COVID-19 S-Trimer vaccine candidate through clinical development, and its robust and differentiated pipeline of vaccines and biologic therapeutics hold great promise to make a difference in other areas.
Data from the World Health Organization showed that currently, there were 235 vaccine candidates in the world, and 63 of them had entered the clinical trial phase.
The vaccine candidates, such as the messenger ribonucleic acid (mRNA) vaccine developed by US-based Pfizer and the recombination vaccine developed by UK-based AstraZeneca, had received orders for more than 1 billion doses overseas.
China has 15 vaccine candidates entering clinical trials, with five of them already in third-stage clinical tests.
Among the five candidates, the vaccines produced by Sinovac and China National Pharmaceutical Group (Sinopharm) had been approved for emergency use by more than 16 countries.
China had the largest number of Duolingo English Test candidates last year, she said.
Tian Baoguo, deputy head of the Department of Science and Technology for Social Development at the Ministry of Science and Technology, had said that by the end of October last year, no severe adverse reaction has been reported among the 60,000 volunteers inoculated with the vaccine candidates during the phase 3 trials.
According to a 2019 survey by GlobalData, 84 percent of Chinese consumers seek a balanced and flexible diet that helps them stay healthy as well as look and feel good, making them ideal candidates for plant-based meat alternatives that retain all the flavor of actual meat.
Sinovac Biotech Ltd, a leading provider of biopharmaceutical products in China, announced Monday that Sinovac Life Sciences Co Ltd, a Sinovac subsidiary, has secured approximately $500 million in funding for further development, capacity expansion and manufacturing of CoronaVac, its COVID-19 vaccine candidate, as well as conduct other development and operational activities.
"We have made significant progress in the development of our COVID-19 vaccine candidate CoronaVac, which has reached critical milestones in clinical trials in Asia and Latin America," said Weidong Yin, chairman, president and CEO of Sinovac.
xa0xa0In China,xa0the phase I/II trials were conducted with results showing the vaccine candidate can induce neutralizing antibodies among over 90 percent of volunteers who received two doses of vaccination in both adults and the elderly.
German biotechnology company BioNTech SE and Shanghai Fosun Pharmaceutical (Group) Co Ltd jointly announced on Wednesday that their lead mRND COVID-19 vaccine candidate BNT162b2 will be evaluated in a phase 2 clinical trial.
The online recruitment of volunteers will commence with the recruitment of 960 healthy participants, aged between 18 and 85, to assess the safety and immunogenicity of the vaccine candidate and to support future biologic license applications in China.
Another highlight was Cytiva's support of Clover Biopharmaceuticals to scale up the output of its vaccine candidate, paving the way for the production of COVID-19 vaccines in the future.
Statistics from World Health Organization showed that a total of 44 candidate vaccines worldwide had entered clinical evaluations as of Oct 19, among which 10 were at the final phase of testing.
China currently has 13 vaccine candidates in clinical trials.
One of the inactivated vaccines is from Beijing-based drugmaker Sinovac Biotech Ltd. China National Biotech Group, a unit of State-owned pharmaceutical giant China National Pharmaceutical Group (Sinopharm), is developing the other two inactivated candidates.
After the collection of safety and efficiency data during third-stage clinical trials, vaccine candidates can then apply for official review and approval for market launch.
The company also has the largest population of vaccine recipients in trials among all the vaccine candidates under the same stage of trials.
The Coalition for Epidemic Preparedness Innovations, an innovative partnership launched at Davos in 2017 between public, private, philanthropic and civil organizations to develop vaccines to stop future epidemics, announced Tuesday that it will fund the development of the protein-based S-Trimer COVID-19 vaccine candidate by China's Sichuan Clover Biopharmaceuticals Inc through to licensure, including a global pivotal Phase 2/3 efficacy clinical study beginning before the end of 2020, if the vaccine is proven to be safe and effective.
The coalition's total investment in Clover's S-Trimer vaccine candidate will be up to $328 million, including previously announced commitments of $69.5 million, which have funded preclinical studies and Phase 1 clinical trials, preparations for the global pivotal Phase 2/3 efficacy study and initial manufacturing scale-up activities.
The expanded partnership is a result of Clover's successful early stage clinical development of the S-Trimer vaccine candidate.
Promising preclinical and preliminary Phase 1 data – which will be published in a peer-reviewed publication in the near future - indicate that S-Trimer is well-tolerated and produces strong neutralizing antibody and Th1-biased cell-mediated immune responses, which merit ongoing evaluation of the vaccine candidate, Clover said in a press release.
It will provide full funding for a global pivotal Phase 2/3 efficacy clinical trial of S-Trimer, which is expected to begin before the end of 2020 and aims to generate the necessary safety and efficacy data to support licensure of the vaccine candidate.
Chinese internet search giant Baidu Inc has launched an artificial intelligence-powered service to help candidates that took the national college entrance examination this year choose the universities that best suit them.
The intelligent tool will analyze enrollment plans, admission scores and the universities same-level students have applied for over the past few years, in accordance with the provincial recruitment policies and candidates' personal scores, to provide references for the selection of universities and majors.
Instead of adopting the costlier way of setting up overseas offices, Amber Weather chooses to offer internship opportunities to foreign candidates, which also serves the purpose of getting first-hand insights into local markets, said Song.
Sinopharm Group is speeding up development of a candidate vaccine for the novel coronavirus that causes COVID-19, with more milestones having been achieved by the Chinese State-owned pharmaceutical giant ahead of hoped-for mass production.
Among them, CanSino Biologics is using Sartorius' BIOSTAT bioreactor for developing its coronavirus vaccine candidate that has recently been approved to enter a Phase 2 clinical trial, the first to reach this stage worldwide.
State-owned CNBG teams up with partners to step up development of effective, lasting treatment for COVID-19Chinese State-owned pharmaceutical giant Sinopharm Group has made substantial progress in developing vaccine candidates for the novel coronavirus that causes COVID-19.
Chinese pharmaceutical company Sinopharm said one of its vaccine candidates against thexa0novel coronavirus, which causes COVID-19 disease, has started early human trials after being given the nod for clinical trials from the country's health authorities on Sunday.
Last month, Chinese authorities approved clinical trials for a recombinant vaccine candidate by the Academy of Military Sciences of the People's Liberation Army and Chinese biotech firm CanSino Bio.
After e-commerce success in various regions, Jollychic hits pay dirt in Middle EastEven with a bachelor's degree in computer science from Jordan's Hashemite University, Noor Hayida was turned down by 18 employers for one reason: a female candidate is not welcome.
The company has initiated efforts to develop a coronavirus vaccine candidate and broadly collaborate with others to screen a library of antiviral therapies, according to a press release.
"AGTD was borne out of a previous initiative called the Alibaba Global Leadership Academy, which debuted in 2016 and recruited two batches of candidates who were put on rotation arrangement.
Each interviewee scored candidate companies on nine criteria including management quality, product or service quality, innovation ability, long-term investment value, financial status, ability to attract and maintain talent, social responsibility, reasonable utilization of assets, and effectiveness of global operations.